Effects of Capros in Patients With Type-1 Diabetes

Completed · Not applicable

Conditions studied: Type I Diabetes

In brief

The purpose of this 12 week longitudinal study is to test the effect of the dietary supplement, Capros, on blood glycemic index of Type 1 diabetics that have a sensor that provides continuous glucose monitoring (CGM). 20 Type 1 Diabetics will take the Capros supplement for 12 weeks to determine the effect of blood glycemic index. Capros, is a generally safe dietary supplement currently sold over the counter in the United States. Type 1 diabetes also known as juvenile diabetes is commonly diagnosed in children and young adults. Insulin is converted into energy needed for daily living, and with diabetes, insulin is not produced in the body as it should causing many problems. In traditional Indian medicine, the gooseberry Phyllanthus emblica has been used for thousands of years as an effective source of polyphenols and antioxidants. A 12 week longitudinal study to determine the effect of the dietary supplement, Capros, on the blood glycemic index in patients with Type 1 diabetes (T1D).

Key facts

Study ID

NCT02634216

Run by

Ohio State University

People needed

24

Starts

2015-01-01

Expected to finish

2016-05-25

Last updated by the study team

2019-11-20

Who can join

Age: 10 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be 10 - 60 yrs. of age
• Type 1 Diabetes using Continuous Glucose Monitoring (CGM) for at least the last 3 months
• Less than 10% variation in prescribed long acting dosages in the previous 3 months

You may not qualify if…

• Individuals who are deemed unable to understand the procedures, risks and benefits of the study, i.e. informed consent will be excluded from the study
• Females who are pregnant
• Individuals who are therapeutically immuno-compromised
• Prisoners
• Anyone with a known allergy to amla fruit
• Current use of any of the following medications will result in exclusion:
• Steroids (Prednisone, etc.)
• Immunosuppressants
• Accutane (last 6 months)

Where it is running

• Carepoint East 543 Taylor Ave. — Columbus, Ohio, United States
• Martha Morehouse Medical Plaza 2050 Kenny Road — Columbus, Ohio, United States
• Davis Heart and Lung Research Institute — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.